Efficacy of Infection-site-targeted Postural Drainage in Mechanically Ventilated ICU Patients With Pulmonary Infection
A Randomized Controlled Trial of Infection-site-targeted Postural Drainage Combined With Mechanical Vibration for Mechanically Ventilated ICU Patients With Pulmonary Infection
1 other identifier
interventional
384
1 country
1
Brief Summary
This single-center, 1:1 randomized controlled trial aimed to evaluate the efficacy of infection-site-targeted postural drainage combined with mechanical vibration for mechanically ventilated ICU patients with pulmonary infection. Eligible subjects were randomly assigned to either the personalized-care group (PCG, intervention) or routine-care group (RCG, control). Patients in PCG received imaging-guided infection-site-targeted postural drainage plus mechanical vibration. Patients in RCG received standard routine position changes and mechanical vibration without imaging-guided targeted positional adjustment. The primary outcome was duration of invasive mechanical ventilation. Secondary outcomes included PaO₂/FiO₂ ratio, ICU length of stay, total hospital length of stay, and 28-day all-cause mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedFirst Submitted
Initial submission to the registry
September 10, 2026
CompletedFirst Posted
Study publicly available on registry
September 16, 2026
CompletedSeptember 16, 2026
September 1, 2026
2.5 years
September 10, 2026
September 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Duration of mechanical ventilation
From initiation of invasive mechanical ventilation until successful extubation or death, assessed up to day 28.
Secondary Outcomes (4)
28-day mortality
All-cause mortality assessed at 28 calendar days from the date of randomization
PaO₂/FiO₂ ratio
Measured at baseline (X1), Day 1, Day 2, Day 3, Day 4 post-randomization (X2-X4), and at weaning preparation (X5), all within 28 calendar days from randomization
ICU length of stay
From randomization until ICU discharge, assessed up to 28 calendar days from randomization
Total hospital length of stay
From randomization until hospital discharge, assessed up to 28 calendar days from randomization
Study Arms (2)
Intervention group
EXPERIMENTALRoutine-care group
ACTIVE COMPARATORInterventions
Imaging-guided infection-site-targeted postural drainage combined with mechanical vibration chest physiotherapy. The body position is individually adjusted according to pulmonary infection location shown on imaging examinations to facilitate sputum drainage.
Routine regular position change combined with mechanical vibration chest physiotherapy. No imaging-guided targeted positional adjustment is performed; body position is changed following standard ICU nursing protocol only.
Eligibility Criteria
You may qualify if:
- Aged 18-80 years old;
- Admitted to ICU and receiving invasive mechanical ventilation;
- Clinically confirmed pulmonary infection;
- Enrolled between May 2022 and October 2024.
You may not qualify if:
- Unstable systemic disease contraindicating postural changes;
- Active bleeding (gastrointestinal, intracranial, or pulmonary);
- Requirement for continuous renal replacement therapy;
- Raised intracranial pressure;
- Neuromuscular disorder;
- Multiple fractures or major trauma;
- Severe hemodynamic instability;
- Significant arrhythmias;
- Severe delirium or altered mental status;
- Pregnancy or lactation;
- Currently participating in another interventional clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Affiliated Hospital of Jiangnan Universitylead
- Wuxi Taihu Hospitalcollaborator
Study Sites (1)
Wuxi Taihu Hospital
Wuxi, Jiangsu, 214003, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
September 10, 2026
First Posted
September 16, 2026
Study Start
May 1, 2022
Primary Completion
October 30, 2024
Study Completion
October 30, 2024
Last Updated
September 16, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share